Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • Please ensure that the submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file needs to be a Microsoft Word document file format.
  • Where available, DOIs for the references have been provided.
  • The text is double-spaced; uses Times New Roman 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • Please submit the Cover letter, stating clearly all authors names, designationd and contribution of each individual author with their valid e-mail address for communication.
  • Please submit a filled in Copyright transfer form, signed and dated by all the contributing authors, with their emails for all the articles.
  • You will also be required to submit a blinded copy of your manuscript, along with the complete manuscript.
  • Please submit an Ethical Review Letter with submission of an original article.
  • Please submit a Patient consent form, signed by the patient or guardian of the patient (if the patient is a minor) and upload it as Supplementary File before proceeding.
  • The Harvard system needs to be followed for references and citations as per the Journal Guidelines.

Author Guidelines

The Nepalese Journal of Ophthalmology (Nepal J Ophthalmol; NepJOph) is a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society (NOS).

This journal aims to provide an opportunity of sharing knowledge and experience amongst the ophthalmic professionals, as well as help disseminate findings of research and achievements in the ophthalmic field, both at home and abroad.

Original articles, short communications, case reports, review articles etc., on electronic submission are welcome from the academia. Please note that NepJOph publishes articles under the following types/categories/sections.

  • Editorial
  • Guest Editorial (invited only)
  • Original Article
  • Review Article (invited)
  • Case Report/ Case Series (with Literature Review)
  • Brief/ Short Communication
  • Obituary
  • Practice Management
  • Brief Review
  • View Point
  • Protocol
  • Ophthalmology Education
  • Student NepJOph
  • Letter to the Editor
  • NOS News/ Activities
  • Interview
  • Commentaries
  • Miscellaneous
  • Clinical Practice
  • Erratum
  • Acknowledgement

Research works involving human subjects and animals should adhere to international norms and the terms of Declaration of Helsinki of the World Medical Association. Approval from the institutional/ethical review board and informed consent from the subject of study must have been obtained for all experimental studies and articles based on these studies. The NepJOph Editorial Board may request the principal/corresponding author for providing such documents during the process of publication of the manuscript under certain circumstances. We will provide you proof pages before they are published requesting you to check the contents and the style and return back to the editorial office.

Review articles and editorial notes are sometimes invited from national and international renowned authors.

The acceptance for publication of the submitted manuscript is judged by the editorial board through anonymous peer review. The peer reviewers are acknowledged in the subsequent issues of the journal.

Authors are advised to carefully read and comply with the instructions of journal guidelines before submitting their manuscripts.

For publication in NepJOph following submissions are essential:

  1. A cover letter with a declaration of any conflict of interest, stating that the submission has not been sent to any other journal or publishing house besides NepJOph, and confirming the transfer of copyright to NepJOph upon publication. Please review the "Copyright Transfer Statement" provided with the guidelines.
  2. Title page containing authorship details, including signatures of all authors, along with their email addresses, phone numbers, and both online and offline correspondence addresses. It should explicitly state that no other individual(s) besides those listed as authors have any claim to authorship in the submission. The NepJOph follows International Committee of Medical Journal Editors (ICMJE) criteria for authorship: https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. The authors should state the name of the corresponding author with signature, in the same order as it would appear in the final published article. Please state in clear words that all the authors would bear full responsibility in the instance of any authorship disputes or any violation of research ethics. Please check the website of the Committee on Publication Ethics (COPE) for further details at https://publicationethics.org/.
  3. Manuscript with author(s) name(s), affiliation(s), correspondence details, abstract, and references formatted as they would appear in the final published article. We recommend reviewing several (at least 3-4) published articles in the latest issue of NepJOph for clarity and to ensure error-free submission.
  4. Include an ethical clearance letter for Original Articles (and whenever relevant) and a consent form signed by the patient(s) and one or more of the authors(s) for Case Reports/Series. Please refer to the "Patient Consent Form for Case Report" provided in the guidelines.
  1. A blinded copy of your manuscript along with the complete manuscript for peer-review process.

A copyright transfer agreement form, signed by the principal author and all co-authors to confirm their consensus, must be submitted to the editorial office either through online submission or as a scanned copy of the original agreement form via email to editor@nepjoph.org.np at the time of manuscript submission or before publication of the accepted manuscript. Under certain circumstances the Editorial Board may ask for confirming signatures of the other authors as well. The agreement form can be downloaded from the journal’s website: www. nepjoph.org.np and uploaded at the time of paper submission.

Processing Fees

The Nepalese Journal of Ophthalmology does charge authors article submission and processing fees once their manuscript is accepted for publication.

Processing Fees:
Nepalese Journal of Ophthalmology does charge article processing charges to authors once accepted for publication as:

NOS members NPR 1000; Non NOS member Nepalese NPR 1500; SAARC Countries INR 1000; Rest of the World USD 25; and Colour pages are charged additional NPR 2500. The rates are per page charges.

Instructions  

Manuscript preparation and submission

Only those manuscripts written in scientifically correct English are eligible for review process. The Editorial Board may help with some grammatical corrections. However, the authors requiring substantial help are encouraged to get the required assistance by the linguistic experts before submission of the manuscript.

Commercial or proprietary interest to products or companies mentioned in or related to the subject matter of the article being submitted must be disclosed in the covering letter, which may be published at the discretion of the Editor- in Chief.

The manuscript must be submitted online using the website: www.nepjoph.org.np / https://www.nepjol.info/index.php/NEPJOPH/

GENERAL INSTRUCTIONS APPLICABLE TO ALL SUBMISSIONS

The manuscripts may be written in British (UK) English and should be uniform in one submission and comply with the following guidelines:

  • The main title should not exceed 15 words. If you require more than 15 words, please reach out to the NepJOph Editorial Board for assistance.
  • All titles and subtitles/ subheadings should be Bold (Ctrl+B for MS Word in Windows).
  • Font type: Times New Roman (only for convenience).
  • Font-size of the main title of the article: 16 (Title Case) and centrally aligned (Ctrl+Efor MS Word in Windows).
  • List of authors should be in font-size 14, Bold (Ctrl+B for MS Word in Windows), and aligned to the right side of the document (Ctrl+R for MS Word in Windows).
  • Author(s) affiliation: font-size 12 and aligned to the right side of the document (Ctrl+Rfor MS Word in Windows).
  • Correspondence details should be in font-size 12, aligned to the right side of the document (Ctrl+R for MS Word in Windows), and should include only the name and email of the corresponding author. Subtitles or subheadings should be in font-size 12, UPPER CASE, Bold (Ctrl+B for MS Word in Windows), and aligned to the left side of the document (Ctrl+L for MS Word in Windows). The rest of the text/content should be in font-size 12.
  • Page Layout: Size should be A4.
  • Line and Paragraph spacing: Set to 1.15 in MS Word.
  • Alignment: Justify the alignment of the contents on both sides (Ctrl+J for MS Word in Windows).
  • About three to six NOT Keywords or any other variant),which should preferably (not mandatory) be a MeSH Check at https://meshb.nlm.nih.gov/search for more information. Key words should be arranged alphabetically, separated by semicolons, and ending with a full stop. Only the first letter of the first key word upper case, rest lower case. NO abbreviations.
  • Do NOTstart a sentence or statement with a number. E.g., "12 months was follow-up period." should be written as "Twelve months was follow-up period." Please write the single-digit numbers (zero to nine) in  E.g., 0 to 9 should be written as zero to nine, three months not 3 months. Please also avoid starting a sentence with an abbreviation. Not mandatory though. No space between greater than, lesser than symbols and numbers. > 20 < 30 should be >20 <30; Keep space with text (e.g., p <0.001).
  • AVOID “our/my, we, us” etc. Instead of our study, better write this/current/present study. The authors NOT “we”. In scientific writing, whenever possible, please prefer writing in: Past tense, Third person, Indirect speech, and Passive voice (not mandatory).
  • About abbreviations,first use the word in full form, followed by its abbreviation in brackets, then only you may use the abbreviation independently. Mentioning any abbreviation in the ABSTRACT section does not count for the main body. Avoid abbreviations in the titles and sub-titles. Do not begin a sentence with an abbreviation. E.g., "Nepal Ophthalmic Society (NOS) was established in year 1985. The NOS started publishing its journal from the year 2009." The authors are advised not to use any unusual abbreviations. Drugs’ names should be affirmed in standard chemical or generic nomenclature. Unit of measure should conform to International System (SI) units.
  • For NepJOph, use the following symbols, in sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡, §§, ||||, ¶¶, etc.
  • For Financial interest or Conflict of interest, you may write"Nil" if no conflict. If any conflict of financial disclosure, please mention. More elaborate financial support not falling under “Conflict of interest” can be mentioned under the ACKNOWLEDGEMENT section.
  • The Harvard system needs to be followed for references and citations as per the Journal Guidelines.
  • If any confusion, first check a few (recommended is at least 3-4) published articles under the same category in the latest issue; if still, it is not clear, please feel free to contact the NepJOph editorial team.
  • When you submit the revised manuscript/article, please send two documents: one clean copy without any comments or track changes, the other with track changes showing the changes you have made after editor/reviewer’s comments.

The title page should contain the following information: title of the manuscript, manuscript category (original article, brief communication, case report or review article), full name(s) of author(s), with their affiliated institution(s) and their full address(es), word count of abstract, word count of text, number of references, number of illustrations and/or figures, number of tables, number of pages, commercial interest, a running title with not more than 50 characters, name and address of the corresponding author including fax number, e-mail address and telephone number.

In the case of multiple authors, please ensure that the person(s) who receive(s) authorship has/have contributed significantly in designing the study, analyzing data, manuscript writing and was/ were involved in the treatment of study subjects. Financial contributors and simple advisors should be acknowledged in the last paragraph of the manuscript, after conclusion. The number of authors should not generally exceed six. Only one person can be the first author.

Title and Authorship Format

Title should be in title case (upper case for all initial letters, mainly nouns, and pronouns) and in centre alignment (Ctrl+E in MS Word in Windows). E.g.,

Ocular Findings among the Patients of Renal Transplantation

 

The authors’ names should be in full (complete name), right alignment (Ctrl+R in MS Word in Windows), and NEPJOPH does not follow any prefix of Mr./Ms./Dr., etc in authors list (you may mention that under Corresponding Author section).

The superscripts for institutional/ organizational affiliations should be placed before full name and comma. The authors with the same affiliation will have the same superscript, while different affiliations will have different superscript marked by a separate Hindu-Arabic number in sequence. E.g.,

Samiksha Bhattarai1, Poonam Lavaju1, Badri Prasad Badhu2, Sangeeta Shah1, Santosh Chaudhary1, Robin Maskey1, Ashesh Koirala1

 

1B.P. Koirala Institute of Health Sciences, Dharan, Sunsari, Nepal

2Birat Medical College, Biratnagar, Morang, Nepal

 

For Corresponding Author (NOT Address for correspondence; correspondence; corresponding address; or anything else), the details (designation, department, institute, address: name of place, district, country) should be mentioned (except phone number) as it would appear in the final published article. Please also note to write E-mail with hyphen NOT Email. E.g.,

Corresponding Author

Dr. Samiksha Bhattarai

Lecturer, Department of Ophthalmology,

B.P. Koirala Institute of Health Sciences,

Dharan, Sunsari, Nepal.

E-mail: saumri.6112@gmail.com 

 

For any conflict of interest or financial disclosure please mention or write Nil if no conflict or financial support. E.g.,

Financial interest: Nil.

Conflict of interest: Nil.

 

Legends of Table and Figures

Tables and Figures: not more than six in total (For Case Report/Series, please check below as well as under the relevant section). Please do not merge/collage multiple "Figures/Pictures" to make one. They will be counted as individual figures/pictures and not accepted in NEPJOPH if the figure limit is crossed.

For all manuscripts except Case Report/Series, the numbers of Tables and Figures should not be more than six, both combined. For Case Report, it shall have no more than 12 figures and Case Series can have up to 24 figures. Under special circumstances, if you need to have more than the allowed number of tables/figures, kindly contact the NEPJOPH Editorial Board. 

Please keep both frequency and percent in same column with brackets. Please keep space between frequency and bracket arm of percent. Do not write 23(42.7%), instead write 23 (42.7%). No need to repeat % symbol in each box (of each row and column) if already mentioned in the title. E.g., 23 (42.7).

The main headings in Tables should be centrally aligned. For the contents of the table, all text should be left-aligned and numbers centrally aligned.

The legends of tables should be written ABOVE the tables while for figures they should be written BELOW the respective figures. In NepJOph, graphs, charts, bar diagrams, photographs, etc., are kept all under the FIGURE heading. So, no other headings besides, the Tables or Figures.

Though it is not mandatory, NepJOph prefers full forms instead of abbreviations in the legends. Also, it is preferred that high-quality pictures/photographs should be attached separately as well, in addition to keeping in the manuscript.

Table number colon legend full stop

(The first letter of the first word uppercase, rest lowercase)

E.g.,

Table 3: Correlation of metabolic blood parameters with average central macular thickness.

Figure 2: Scatter plot between average central macular thickness and urea. 

 

REFERENCES

Plagiarism in any form is not accepted. Any works done by others, if cited in your text must be properly referenced. References should be limited to those cited in the text following the Harvard referencing system.

REFERENCES should be no more than eight for Editorial, Guest Editorial, Letter to the Editor, NOS News/Activities, Commentaries, and Miscellaneous sections. A maximum of 10 references for Case Report, Brief/Short Communication, View Point, Ophthalmology Education, and Student NepJOph sections. No more than 30 references for Original Article, Protocol, and Case Series (with Literature Review). A maximum of 50 references for the Review Article section is allowed.  

 

Harvard referencing system

The Nep J Oph expects authors to use the alphabetical or name-date method known as the Harvard system. In this system, the author’s surname and year of publication are cited in the text, e.g. Albanese et al (2003), and a reference list (of these citations) is included at the end of the assignment, in alphabetical order by author. The reference list also includes additional details such as the title and publisher.

Example of listing Harvard referencing system

Albanese MA, Snow MH, Skochelak SE, Huggett KN, Ferrell PM (2003). Assessing personal qualities in medical school admissions. Academic Medicine; 78 (4) : 313-321. References to sources may be cited in the text in different ways depending on the nature of the sentence/paragraph that is being written. Various examples are given below.

Author’s name cited in the text

Dewey (1991) believed the process of behavior changes was critical to reflective learning.

 

Author’s name not cited directly in the text

As humans we all try to make sense of the world in any way we can, gathering information of varying accuracies, constantly developing intuitive theories, and interpreting situations in a manner that fits the theories we have previously developed (Gilovich, 1993).

More than one author cited in the text

Bransford et al (1999) outlined the …… important characteristics of expertise.

More than one author not cited directly in the text

In a recent review that was published in the Lancet the authors identified major impediments to improving mental health services in countries such as …..(Saraceno et al, 2007).

Or

Our conceptual framework for understanding education in the teaching clinics is to adopt an experiential learning model (Kolb, 1984; Jarvis, 1995; Smith & Irby, 1997).

Two authors for the same work

Reliability coefficients in many OSCEs show considerable variation and unevenness in magnitude (Pedhazur & Schmelkin, 1991).

More than two authors for a work

Ginsburg et al (2004) have recently examined differences between the formal admissions policy implemented for residency selections and the informal understanding…..

Several works by one author in different years

(Upadhyay 1993, 1997)…….

Several works by one author in the same year

Earlier research by Badhu (1997a) found that… but later research suggested again by Badhu (1997b) that……

Corporate authors

B P Koirala Institute of Health Sciences (BPKIHS), 1996

(B P Koirala Institute of Health Sciences, 1996) BPKIHS, 1996 (in case of second citation)

Chapters of edited books

For chapters of edited books, the required elements for a reference are:

Chapter author(s) surname(s) and initials. Year. Title of chapter followed by ‘In’

Book editor(s) initials and surnames with ed. or eds. after the last name.

Title of book. Place of publication: Publisher. Chapter number or first and last page numbers followed by full-stop.

Smith J. (1975). A source of information. In W. Jones, ed. One hundred and one ways to find information about health. Oxford: Oxford University Press. Ch. 2.

Samson C. (1970). Problems of information studies in history. In S. Stone, ed. Humanities information research. Sheffield: CRUS, 1980, p. 44-68.

(Note: for more details of the Harvard Referencing system please refer to http:// libweb.anglia.ac.uk/ referencing/harvard.htm)

 

SPECIFIC INSTRUCTIONS FOR EACH SUBMISSION CATEGORY

 

Instructions for Editorial/ Guest Editorial

They are written by invitation or produced in-house. It would state the opinions expressed in editorials and those of the author alone. They are in no way intended to express the official viewpoint of the journal, the board, or NepJOph. Up to 800 words excluding references which in turn are restricted to a maximum of eight in number are allowed.

 

Instructions for Original (Research) Article

ABSTRACT - word limit-300 excluding key words. Structured as: Introduction; Objective; Methodology; Result; Conclusion. 

Key words:  About three to six “Key words” (NOT Keywords or any other variant), which should preferably (not mandatory) be a MeSH term. Check at https://meshb.nlm.nih.gov/search for more information. Key words should be arranged alphabetically, separated by semicolons, and ending with a full stop. Only the first letter of the first key word upper case, rest lower case. NO abbreviations.

 

INTRODUCTION in a maximum of 300 words. Anything extra can be strategically placed in METHODOLOGY or DISCUSSION sections.

State the background of the study, rationale (justification), and objective. In the background, the information should be given as global, regional, and local. Please note that INTRODUCTION section is written in present tense EXCEPT the objective.

METHODOLOGY

State the a) study design, b) place and duration of the study, c) sample size and sampling technique, d) inclusion and exclusion criteria, e) ethical approval and informed consent, and f) statistical analysis and software used. Please do not use separate headings for study design (and other topics mentioned in the previous sentence) or other headings for inclusion criteria, exclusion criteria, data analysis, etc. Also, mention everything in paragraphs, not bullets or numbers.

RESULT

State the main findings first then move towards the rest of the findings. All the findings should be in n (%) format, which means both frequency and percent whenever applicable. Please write mean and standard deviation using ± symbol instead of brackets: E.g. 27.56 ± 1.39; NOT 27.56 (1.39).

All tables and figures (for graphs, please use the term figure for convenience) should be mentioned in content/text also. When you mention Table or Figure in content, keep them within brackets. E.g., (Table 4) not …. depicted in Table 4. Please write BOTH frequency as well as percent above the graphs/bars/pie charts and Tables in n (%) format. Please write frequency and percent in same column in Tables. No need of decimal places if 0 after decimal. E.g., 16.0% should be 16%.

For decimal values in findings, please mention up to one or two decimal values. If you are keeping two numbers after decimal, keep two at all places in one article. However, if you want to keep only one digit after decimal, keep one in one submission. Just be uniform, except for p-value and standard deviation, where you can keep up to three numbers after decimal but please be uniform throughout one submission or document. In tables, boxes with zero values can just have hyphen.

NepJOph writes “p-value” NOT P value, p value, p-value, p value or any other forms. The p-values should not be listed as not significant (NS) since, for meta-analysis, the actual values are important and not providing exact p-values is a form of incomplete reporting. The actual p-value should be expressed (p = 0.04) rather than expressing a statement of inequality (p <0.05), unless p <0.001). Do not write p = 0.000 instead write it as p <0.001. The p-value 0.000 should be written as p-value <0.001 (as p = 0.000 is impossible though some statistical software report it like that). Please do not have p-values more than three digits after decimal. Expressing p to more than three significant digits does not add useful information since precise p-values with extreme results are sensitive to biases or departures from the statistical model. In rare instances, p-values may be expressed to more than three decimal places such as in genome-wide association studies, studies involving Bonferroni correction, etc. Please consult NepJOph team for that. There should be no space between greater/lesser than symbol and number, if word/text then keep space

In the legends of tables and figures, write the complete words, preferably no abbreviations: "Table Table number separated from the title by a colon" and Figure, not Fig. The title should be in "Sentence Case" and the table or figure number separated by a colon. The first letter of title upper case, rest all lower case.

Table 1: Title should be in brief.

Figure 1: Title should be simple.

For detail please check under general instructions for the "Legends of Tables and Figures" section.

DISCUSSION (Please write limitations within it).

CONCLUSION The conclusion section should not contain the numeric findings but the conclusion you have drawn from the findings. Please write "recommendation" within this section. 

ACKNOWLEDGEMENT (optional and no more than 100 words).

Just name the individual or organization. Please do not use this section as a praising platform for your bosses, seniors, family, friends, colleagues, and others.  

REFERENCES: No more than 30 references are allowed.  

NO OTHER HEADINGS besides these. For legends of tables and figures, check under the general instructions.

Total word limitation - 3000 excluding abstract, references, and legends of tables and figures.

 

Instructions for Review Article

ABSTRACT - word limit-300 excluding key words.  Structured as: Introduction; Objective; Methodology; Result; Conclusion. 

Key words:  About three to six “Key words” (NOT Keywords or any other variant), which should preferably (not mandatory) be a MeSH term. Check at https://meshb.nlm.nih.gov/search for more information. Key words should be arranged alphabetically, separated by semicolons, and ending with a full stop. Only the first letter of the first key word upper case, rest lower case. NO abbreviations.

INTRODUCTION in a maximum of 300 words should include the background of the review, rationale for doing the review. Main points to focus.

OTHER APPROPRIATE HEADINGS (Main headings should be in UPPER CASE while Sub headings can be in Title Case or Sentence case as appropriate)

CONCLUSION

ACKNOWLEDGEMENT (optional and no more than 100 words)

Just name the individual or organisation. Please do not use this section as a praising platform for your bosses, seniors, family, friends, colleagues, and others.  

REFERENCES: A minimum of 30 references and no more than 50 references. 

For legends of tables and figures, check under the general instructions.  

Total word limitation - 4500 excluding abstract, references, and legends of tables and figures.

For a Systematic Review or Meta-analysis, please follow the PRISMA recommendations. You can access the relevant information from their website at http://www.prisma-statement.org/

  

Instructions for Case Report/ Case Series (with Literature Review)

ABSTRACT - word limit-300 excluding key words. Please write the ABSTRACT section under these headings: Introduction, Case, Observation, Conclusion.

Case Report should have a maximum of four authors but no limit on the number of authors for Case Series with Literature Review.


Case Report should have no more than four patients while five to 10 patients can be reported in Case Series with Literature Review. That means a Case Series should not report more than 10 patients.

Case Report shall have no more than 12 figures and Case Series can have up to 24 figures. Under special circumstances, if you need to add more figures please contact NepJOph Editorial Team.

Please do not merge/collage multiple "Figures/Pictures" to make one. They will be counted as individual figures/pictures and not accepted in NEPJOPH if the figure limit is crossed.

Key words:  About three to six “Key words” (NOT Keywords or any other variant), which should preferably (not mandatory) be a MeSH term. Check at https://meshb.nlm.nih.gov/search for more information. Key words should be arranged alphabetically, separated by semicolons, and ending with a full stop. Only the first letter of the first key word upper case, rest lower case. NO abbreviations.

INTRODUCTION in a maximum of 300 (same for case series) words should include the background of the case being reported. 

CASE REPORT The case(s) being reported should be new/interesting/rare with clinical significance or implications.  

DISCUSSION

Other Appropriate headings: 

CONCLUSION  

ACKNOWLEDGEMENT (optional and no more than 100 words).

Just name the individual or organisation. Please do not use this section as a praising platform for your bosses, seniors, family, friends, colleagues, and others.  

REFERENCES: No more than 10 references except for "case report with literature review" where a maximum of 30 references is allowed. 

For legends of tables and figures, check under the general instructions. 

Total word limitation - 1500 (3000 for case report with literature review) excluding abstract, references, and legends of tables and figures.

 

Instructions for Letter to the Editor

It should be up to 400 words and cite a maximum of eight references and may concern any item felt to be of interest to the readership, or more usually be a question or critique concerning a paper. Letters may be subject to peer review.

 

Instructions for the View Point

The articles under this heading are the personal opinions and perspectives that allow the author(s) to express their own point of view on issues relevant to health. They should be of scientific or clinical value. The purpose may be to raise awareness, new ideas, thought-provoking concepts, and personal expert opinion to improve health. Current or ongoing controversial topics are recommended to be probed into. Up to 1000 words excluding references which in turn are restricted to a maximum of 10 in number are allowed.

 

Instructions for Brief Communication/Miscellaneous/ Commentaries

Submission based on some experience, education, or a variety of topic which has some clinical or scientific value that does not fall under any of the above categories. Word limit – 800. References - maximum of eight in number.

 

NOS News/Activities

This section includes information about various activities of NOS. The submission to this section is open to Nepal Ophthalmic Society only.

 

 

Note: It is also required that the corresponding author clearly specifies the type of article s/he is submitting. However, the final decision under which category the article is published rests on the decision of the NepJOph editorial board. In such a case, the author will be duly informed regarding the decision. The author will have the right to withdraw the article if s/he chooses but must do so within the specified time. For more details, please check at: https://www.nepjol.info/index.php/NEPJOPH/about/submissions

 

Peer Review:
The Nepalese Journal of Ophthalmology has a double blind process for the review. The articles submitted are reviewed by the national and international experts in the respective fields after the initial screening by the editorial board. We ensure that the peer reviewer is not from the same institute as that of the any of the authors and does not have any conflict of interest to the work. It will be sole right of the editorial board to decide the reviewers for the manuscript. The review process from the reviewer is usually one month and if there is not respons, it will be sent to another reviewer. The whole process of review will take from 6 weeks to 4 months, depending on the significance of the article.

The article is sent to at least two reviewers, with one of them being an international expert. Once the reviewers comments are received, the authors are asked to resubmit their manuscript by incorporating the reviewers comments. if both the reviewers reject the article, the editorial board will reject it. However, the final decision of the paper acceptance is reserved by the editorial board. 

Copyright:
It is mandatory that a copyright transfer agreement form signed by the principal author and all the co-authors confirming the consensus of all the authors be submitted to the editorial office by fax (00977-25-520251 or 530119) or a scanned copy of the original agreement form by e-mail to editor@nepjoph.org.np at the time of manuscript submission or before publication of the accepted manuscript. Under certain circumstances the Editorial Board may ask for confirming signatures of the other authors as well. The agreement form can be downloaded from the journal’s website: https://nos.com.np/s/nepalese-journal-of-ophthalmology/ and uploaded at the time of paper submission. Without the form, the article will not be processed for review. The copyright agreement form can be found here. Please insert signatures and dates from all authors and upload it at the time of paper submission.

Creative Commons License
Articles in the Nepalese Journal of Ophthalmology are Open Access articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, is not changed in any way, and is not used for commercial purposes.

 

Patient Consent form for Case Reports:
Please submit the patient consent form, signed by the patient or Guardian of the patient is a minor. Without it, the article will not be processed further. Please upload it in the supplementary file during the submission of case report.

Plagiarism
The journal will check all submitted articles for plagiarism using the Crossref Similarity Check software.


Disclaimer: The research studies, statements, expressions, and opinions in the articles are solely of the authors and do not represent the official stance of the editorial board the Nepalese Journal of Ophthalmology (NepJOph) or of the Nepal Ophthalmic Society (NOS). Advertisements or products mentioned in the journal cannot be considered as endorsement by the editorial board or the NOS. Neither NepJOph nor NOS shall be held responsible, under any circumstances, for any loss or harm due to information provided in NepJOph.

 

The Editorial Board would also like to thank you for sharing your time with us. We expect your continued support in this academic endeavour. And we feel privileged to have the opportunity of presenting the Nepal J Ophthalmol to the ophthalmic academia.

Dr Eli Pradhan,

Editor-in-Chief

Tilganga Institute of Ophthalmology

GPO Box 561, Gaushala, Bagmati Bridge

Tel: 01-4493775, 4493684

Fax: 977-1-4474937

 E-mail: editor@nepjoph.org.np

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)